We are live on ! Find out more
HTC

Haverford Trust Company Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.64%
This Fund
S&P 500
This Quarter Est. Return
+11.93%
1 Year Est. Return
+18.64%
3 Year Est. Return
+50.3%
5 Year Est. Return
+61.01%
10 Year Est. Return
+205.82%
AUM
$8.12B
AUM Growth
+$822M
Cap. Flow
+$23.3M
Cap. Flow %
0.29%
Top 10 Hldgs %
31.18%
Holding
346
New
12
Increased
102
Reduced
147
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 16.16%
2 Technology 16%
3 Financials 12.06%
4 Consumer Staples 10.22%
5 Consumer Discretionary 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$337M 4.15%
2,593,533
-35,316
-1% -$5.05M
MSFT icon
2
Microsoft
MSFT
$3.45T
$318M 3.91%
1,324,644
+826
+0.1% +$198K
UNH icon
3
UnitedHealth
UNH
$376B
$255M 3.14%
481,235
-685
-0.1% -$363K
JPM icon
4
JPMorgan Chase
JPM
$935B
$240M 2.95%
1,786,744
+5,192
+0.3% +$658K
JNJ icon
5
Johnson & Johnson
JNJ
$618B
$238M 2.93%
1,346,626
+9,552
+0.7% +$1.65M
PEP icon
6
PepsiCo
PEP
$190B
$237M 2.91%
1,310,244
+5,066
+0.4% +$904K
BLK icon
7
Blackrock
BLK
$169B
$234M 2.88%
329,646
+1,355
+0.4% +$905K
IEMG icon
8
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$229M 2.82%
4,905,004
-469,371
-9% -$21.3M
MA icon
9
Mastercard
MA
$502B
$227M 2.79%
652,702
+3,485
+0.5% +$1.15M
LOW icon
10
Lowe's Companies
LOW
$117B
$219M 2.69%
1,097,703
+6,042
+0.6% +$1.21M
CVS icon
11
CVS Health
CVS
$133B
$213M 2.63%
2,288,090
-14,599
-0.6% -$1.41M
ACN icon
12
Accenture
ACN
$102B
$205M 2.53%
769,811
+3,916
+0.5% +$1.08M
DG icon
13
Dollar General
DG
$28B
$204M 2.52%
830,084
-336
-0% -$83.1K
RTX icon
14
RTX Corp
RTX
$290B
$204M 2.51%
2,020,489
-2,192
-0.1% -$206K
IJR icon
15
iShares Core S&P Small-Cap ETF
IJR
$109B
$198M 2.44%
2,090,538
+6,950
+0.3% +$667K
HON icon
16
Honeywell
HON
$77B
$187M 2.3%
925,714
-38,467
-4% -$7.35M
IVV icon
17
iShares Core S&P 500 ETF
IVV
$878B
$163M 2.01%
424,962
+121,313
+40% +$46.8M
TJX icon
18
TJX Companies
TJX
$174B
$158M 1.94%
1,978,691
+6,404
+0.3% +$473K
COST icon
19
Costco
COST
$422B
$156M 1.92%
341,761
+2,567
+0.8% +$1.25M
ORCL icon
20
Oracle
ORCL
$374B
$139M 1.71%
1,701,297
+53,986
+3% +$4.1M
BDX icon
21
Becton Dickinson
BDX
$45.6B
$132M 1.62%
518,588
-2,023
-0.4% -$478K
APD icon
22
Air Products & Chemicals
APD
$65.7B
$131M 1.61%
424,653
+3,391
+0.8% +$956K
IEFA icon
23
iShares Core MSCI EAFE ETF
IEFA
$190B
$127M 1.56%
2,058,519
-122,696
-6% -$7.22M
IJH icon
24
iShares Core S&P Mid-Cap ETF
IJH
$122B
$124M 1.52%
2,554,225
+24,450
+1% +$1.18M
SPGI icon
25
S&P Global
SPGI
$121B
$113M 1.4%
338,390
+9,504
+3% +$3.13M

Similar funds

Haverford Trust Company's Q4 2022 Portfolio in Review

As of Q4 2022, Haverford Trust Company held 346 positions worth $8.12B, up 11% from $7.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Haverford Trust Company's Q4 2022 filing shows 12 new, 102 increased, 147 reduced and 16 closed positions. Its largest new stake was Avantis Emerging Markets Equity ETF: 1,052,828 shares worth $53.1M. The largest sale was Goldman Sachs ActiveBeta Emerging Markets Equity ETF, an estimated $56.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

  • Haverford Trust Company's largest Q4 2022 buy was Avantis Emerging Markets Equity ETF: 1,052,828 shares worth $53.1M.
  • Haverford Trust Company added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $46.8M increase.
  • Haverford Trust Company's biggest Q4 2022 reduction was Goldman Sachs ActiveBeta Emerging Markets Equity ETF, cutting an estimated $56.2M.
  • Haverford Trust Company fully exited Alerian MLP ETF in Q4 2022, selling an estimated $572K.
  • Haverford Trust Company's ten largest holdings make up 31% of its $8.12B portfolio in Q4 2022.
  • Haverford Trust Company opened 12 new positions and closed 16 in Q4 2022.
  • Haverford Trust Company's portfolio value rose 11% quarter-over-quarter to $8.12B.

Based on Haverford Trust Company's 13F filing for Q4 2022, filed 13 Feb 2023.